563
Views
6
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center’s early clinical experience

, MBChB & , MD
Pages 521-524 | Received 22 Jan 2019, Accepted 03 Feb 2019, Published online: 22 Feb 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Y. T. Lim, T. C. Williams, R. J. Langley & E. Weir. (2024) Mepolizumab in children and adolescents with severe eosinophilic asthma not eligible for omalizumab: a single Center experience. Journal of Asthma 0:0, pages 1-8.
Read now

Articles from other publishers (5)

Olaia Sardon-Prado, Carolina Diaz-Garcia, Paula Corcuera-Elosegui, Javier Korta-Murua, Jose Valverde-Molina & Manuel Sanchez-Solis. (2023) Severe Asthma and Biological Therapies: Now and the Future. Journal of Clinical Medicine 12:18, pages 5846.
Crossref
Alesha Wale, Zoe Young, Wenjuan Zhang, Sarah Hiom, Haroon Ahmed, Rowan Yemm & Efi Mantzourani. (2023) Factors affecting the patient journey and patient care when receiving an unlicensed medicine: A systematic review. Research in Social and Administrative Pharmacy 19:7, pages 1025-1041.
Crossref
Armando Partida-Gaytán, Luis Torre-Bouscoulet, Marco Polo Macías, Alejandro Raimondi & Emilio Pizzichini. (2021) Mepolizumab para el tratamiento de asma grave eosinofílica. Revista Alergia México 67.
Crossref
Yu. L. Mizernitskiy, I. M. Mel'nikova & V. A. Pavlenko. (2020) Mepolizumab in the treatment of bronchial asthma in children. Meditsinskiy sovet = Medical Council:1, pages 81-86.
Crossref
Markus F. Neurath. (2019) Resolution of inflammation: from basic concepts to clinical application. Seminars in Immunopathology 41:6, pages 627-631.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.